https://www.selleckchem.com/products/arv-110.html
Fertility sparing surgery for patients with early stage ovarian clear cell carcinoma is controversial. We aimed to investigate the impact of fertility sparing surgery on the oncologic outcomes of young patients with stage I ovarian clear cell carcinoma. The National Cancer Database was accessed and patients with pathological stage IA or IC ovarian clear cell carcinoma, aged 45 years, were selected. Based on site specific surgery codes, patients who underwent fertility sparing or radical surgery were identified. Overall survival was eval